Ultra Processed Foods Consumption and Impact in Rheumatic Diseases.
- Conditions
- Rheumatoid ArthritisSpondyloarthritisOsteoarthritis
- Registration Number
- NCT06776965
- Lead Sponsor
- Hospices Civils de Lyon
- Brief Summary
Ultra-processed foods (UPF) represent one of the mainstays of today's diet. They are defined by the NOVA classification system. It was demonstrated that UPF consumption was associated with activity of inflammatory bowel diseases with underlying mechanisms not fully identified yet. It is suspected that UPF constituents could modify the gut microbiota, increase intestinal barrier permeability and directly engage immune surveillance systems, effects that could individually or synergistically increase the risk of immunomediated diseases. As some pathophysiological mechanisms are shared among IBD and rheumatic diseases, we have wondered if UPF consumption could be associated with increased risk of rheumatic disease and/or with their activity.
Our primary aim will be to study the pattern of UPF consumption in patients with rheumatic diseases. Our secondary objectives will be to study the activity of diseases according to UPF consumption.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 240
- Age > 18 years
- chronic rheumatic disease (Rheumatoid arthritis, spondyloarthritis, osteoarthritis)
- ability to perform questionnaires
- Judicial protection measure
- Refusal to participate in the study
- Suffering from 2 rheumatic disease simultaneously
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Describe the consumption of ultra-processed foods in patients with chronic inflammatory rheumatism At baseline Describes the consumption of ultra-processed foods in patients with chronic inflammatory rheumatism using a self-assessment questionnaire (Score UPF Nova Screener) completed at baseline, 6 and 12 months.
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Edouard Herriot Hospital
🇫🇷Lyon, France